Shopping Cart
- Remove All
- Your shopping cart is currently empty
Nrf2 activator-9 (compound D-36) is an agent that mitigates oxidative stress by inhibiting the apoptosis of HUVEC cells induced by oxidized low-density lipoprotein (oxLDL) and high glucose (HG), also protecting vascular endothelial cells (VEC) from oxLDL and HG-induced injury, offering potential therapeutic benefits for atherosclerosis prevention and treatment [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | Inquiry | Backorder | |
50 mg | Inquiry | Backorder |
Description | Nrf2 activator-9 (compound D-36) is an agent that mitigates oxidative stress by inhibiting the apoptosis of HUVEC cells induced by oxidized low-density lipoprotein (oxLDL) and high glucose (HG), also protecting vascular endothelial cells (VEC) from oxLDL and HG-induced injury, offering potential therapeutic benefits for atherosclerosis prevention and treatment [1]. |
In vitro | Nrf2 activator-9 (compound D-36) at 5 μM and 10 μM for 6 hours reversed HUVEC apoptosis induced by 50 μg/mL oxLDL [1]. At the same concentrations for 6 and 24 hours, it promoted nuclear translocation of Nrf2 and activated its antioxidative pathway, thereby protecting HUVECs [1]. |
Molecular Weight | 473.52 |
Formula | C26H27N5O4 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.